info@marketresearchfuture.com   📞  +1 (855) 661-4441(US)   📞  +44 1720 412 167(UK)
Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Ovulation Test Market Research Report Information By Type (Urine-based Tests, Saliva-based Tests, and Other Tests), By Application (Hospital, Home Care Settings, Clinics, and Others), and By Region (North America, Europe, Asia-Pacific, and Rest Of The World) – Market Forecast Till 2032


ID: MRFR/LS/0833-HCR | 80 Pages | Author: Kinjoll Dey| June 2024

Global Ovulation Test Market Overview


Ovulation Test Market Size was valued at USD 2.5 Billion in 2022. The Ovulation Test market industry is projected to grow from USD 2.7 Billion in 2023 to USD 4.3 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 6.30% during the forecast period (2024 - 2032).Globally, there are more and more illnesses emerging, including Polycystic Ovary Syndrome (PCOS), other health problems, more first-time mothers, and poor fertility rates, are the key market drivers enhancing the market growth. 


Ovulation Test Market


Type: Secondary Research, Primary Research, MRFR Database and Analyst Review


November 2023: Premom Easy@Home ovulation test strips were called by the reputable site, The Bump, the 2023 Best Ovulation Test Strips in the Best of The Bump Awards, a yearly competition where the site thoroughly tests a range of baby and pregnancy products for new and aspiring parents. Premom Easy@Home ovulation strips have a high appreciation for precision, affordability, and ease of use, making them a top solution in the reproductive health industry. Easy@Home's Ovulation Test Strips are intended to help women recognize their most fertile days with ease and precision. The strips use innovative technology to detect the rise in luteinizing hormone (LH) or LH surge, signaling the onset of ovulation. What places Easy@Home apart is the incorporation of its ovulation test strips with the advanced Premom Ovulation Tracker app, one of the leading fertility tracker apps available. The robust blend strengthens women with innovative features and personalized insights, transforming the way they track and understand their fertility.


November 2023: A YC alum, Inito, which assists women in tracking fertility hormones swiftly at home, has managed to raise USD6 million in Series A funding led by Fireside Ventures. The startup's fertility monitors, and kit are intended to offer users easy-to-read fertility diagnostic results straight to their phones in just 10 minutes. The Bengaluru, India-based startup was established in 2015 by CEO Aayush Rai and CTO Varun A Venkatesan, who priorly was employed at MedTech giant Siemens. Rai worked on product development, while Venkatesan was a researcher for medical products. The pair started bonding during their Sunday kayaking sessions and chatted about how they wished to spend their lives doing something that impacted people's lives.


Ovulation Test Market Trends



  • Rising in various types of diseases such as Polycystic Ovary Syndrome (PCOS) is driving the market growth


The market for ovulation tests would be driven by the increase in different disorders including Polycystic Ovary Syndrome (PCOS) and other health problems. In addition, a rise in first-time pregnancies and low fertility rates globally will propel the ovulation test industry in the years to come. The majority of nations are now technologically developed and using digital testing methods. The market for ovulation tests is expanding as a result of the increase in ovulation testing acceptance in these nations and the availability of cutting-edge technology with high accuracy. The market for ovulation tests is anticipated to grow as family planning becomes more widely known. Globally, pregnancy test kit complications are on the rise, which is predicted to accelerate the growth of the ovulation test market. The ovulation test kit is reasonably priced, provides results that are 99% accurate from home, and is drawing vendors. This market will grow in the upcoming years due to the need to prevent unintended pregnancies and maintain better healthcare facilities for children.


The market participants have a significant chance due to the rise in ovulation test sales online. The nearest drug stores are where you may purchase the ovulation testing equipment. Since these gadgets are over-the-counter, a prescription is not necessary to purchase them. This makes marketing these products to online retailers simpler. These products can be purchased from a number of online retailers, including Amazon, Flipkart, and Walmart. The market participants are also putting plans into practise to sell the ovulation testing equipment online through the business website. They have launched a private online store for their goods. For instance, the Modern Fertility company has begun selling its goods on its own online store. It is projected that these kinds of tactics would open up profitable opportunities for the expansion of the ovulation test industry.


The ovulation test market is expanding as a result of rising first-time pregnancy ages, rising populations of women of reproductive age, and rising gynaecological practises. Due to a larger propensity for delaying first pregnancy, the OECD reports that the average age at which women give birth currently is 30 or higher. The age at which women give birth has altered as a result of changing lifestyles, with women becoming more autonomous and delaying motherhood until they are older. Additionally, the market is seeing potential for expansion due to rising home testing equipment sales, product development, and awareness. Since they are readily available through e-commerce websites, pharmacies, and retail stores, the demand for home testing devices is rising. Many businesses are engaging in joint ventures to provide benefits to women, for instance. Prega News has entered into a new agreement with Spicejet to introduce a number of initiatives to improve the comfort of pregnant women travelling by air.Thus, driving the Ovulation Test market revenue.


Ovulation Test Market Segment Insights


Ovulation Test Type Insights


The Ovulation Test market segmentation, based on Type, includes Urine-based Tests, Saliva-based Tests, and Other Tests. Urine-based tests segment accounted for the largest revenue share in 2022. Due to rising ovulation prediction kit usage and widespread availability of over-the-counter test kits for at-home testing, the urine-based tests kits segment is the main driver of market expansion.


Ovulation Test Application Insights


 The Ovulation Test market segmentation, based on Application, includes Hospital, Home Care Settings, Clinics, and Others. Home care settings segment dominated the Ovulation Test market in 2022. The shift in patients' attitudes towards self-monitoring of medical disorders and the accessibility of the user-friendly benefit of at-home test equipment are to blame for this. For instance, businesses are now offering ovulation prediction kits that can be used at home to check for the presence of the hormones required for ovulation in the saliva or urine.


Figure 1: Ovulation Test Market, by Application, 2022 & 2032 (USD Billion) 


Ovulation Test Market, by Application, 2022 & 2032


Type: Secondary Research, Primary Research, MRFR Database and Analyst Review


Ovulation Test Regional Insights


By region, the study provides the market insights into North America, Europe, Asia-Pacific and Rest of the World. The North America Ovulation Test Market dominated this market in 2022 (45.80%). This is due to increased client awareness of planned pregnancies, increased client appropriation and usage of the ovulation test kit.Further, the U.S. Ovulation Test market held the largest market share, and the Canada Ovulation Test market was the fastest growing market in the North America region.


Further, the major countries studied in the market report are The US, Canada, German, France, the UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.


Figure 2: OVULATION TEST MARKET SHARE BY REGION 2022 (USD Billion)


OVULATION TEST MARKET SHARE BY REGION 2022


Type: Secondary Research, Primary Research, MRFR Database and Analyst Review


Europe Ovulation Test market accounted for the healthy market share in 2022.This is a result of rising public knowledge of planned pregnancies and the accessibility of ovulation testing tools via e-commerce websites.Further, the German Ovulation Test market held the largest market share, and the U.K Ovulation Test market was the fastest growing market in the European region.


The Asia Pacific Ovulation Test market is expected to register significant growth from 2023 to 2032. This is a result of the growing usage of wealth-checking contraceptive devices. Ovulation test kit and rising subsidizing/ventures for the improvement of ripeness and ovulation screens demand Asia-Pacific to be the region with the fastest growth in the relevant market. This is due to the rapidly growing number of women encountering lifestyle issues.Moreover, China’s Ovulation Test market held the largest market share, and the Indian Ovulation Test market was the fastest growing market in the Asia-Pacific region.


Ovulation Test Key Market Players & Competitive Insights


Leading market players are investing heavily in research and development in order to expand their product lines, which will help the Ovulation Test market, grow even more. Market participants are also undertaking a variety of strategic activities to expand their footprint, with important market developments including new product launches, contractual agreements, mergers and acquisitions, higher investments, and collaboration with other organizations. To expand and survive in a more competitive and rising market climate, Ovulation Test industry must offer cost-effective items.


Manufacturing locally to minimize operational costs is one of the key business tactics used by manufacturers in the Ovulation Test industry to benefit clients and increase the market sector. In recent years, the Ovulation Test industry has offered some of the most significant advantages to medicine. Major players in the Ovulation Test market, including Fairhaven Health LLC, Fertility Focus Limited, NecLife, Swiss Precision Diagnostics GmbH, HiLin Life Products Inc., Geratherm Medical AG, Accuquik, Church & Dwight Co. Inc., Prestige Brands Holdings Inc., Clearblue, and Piramal Healthcare, are attempting to increase market demand by investing in research and development operations.


A firm at the clinical stage is Callitas Health Inc. It works on creating technology for the detection and management of diabetes, obesity, and other gastroenterological conditions. The company offers ToConceive, C-103 Reformulated Orlistat, and Extrinsa as part of their product line. A moisturiser that improves fertility is called ToConceive. Clinical studies have demonstrated that increasing a woman's own natural conception lubricant, known as transudate, can help with conception. FDA-approved for weight loss, orlistat is offered by Roche under the brand names Xenical (on prescription) and alli, respectively. Extrinsa concentrates on arousal and orgasmic issues in females. The non-systemic, topical, and local substance is likewise non-hormonal and has no effect on the CNS. Callitas Health Inc., a company that creates OTC consumer items, clinical-stage pharmaceuticals, and cannabis delivery devices, announced today that it has expanded and altered its initial agreement with NFI Consumer Healthcare. The new agreement asks for the distribution of a co-branded product into the food, drug, and mass retailer markets by ToConceive and NFI's e.p.t®, the OTC pregnancy test kit brand.


The goal of Crown Laboratories, a creator and supplier of skincare goods, is to create a broad range of secure and efficient scientific products for healthy skin. The business specialises in dermatology and offers a broad range of skincare products for cosmetic, therapeutic, and pharmaceutical purposes to help consumers live better lives. L Catterton, the largest worldwide consumer-focused private equity firm, and Crown Laboratories, a prominent, fully integrated, skincare company and portfolio company of Hildred Capital Management LLC, announced the acquisition of StriVectin in August 2021. The transaction is pending regulatory clearances and other usual closing requirements, and it is anticipated to close by the middle of September 2021.


Key Companies in the Ovulation Test market include




  • Fairhaven Health LLC




  • Fertility Focus Limited




  • NecLife




  • Swiss Precision Diagnostics GmbH




  • HiLin Life Products Inc.




  • Geratherm Medical AG




  • Accuquik




  • Church & Dwight Co. Inc.




  • Prestige Brands Holdings Inc.




  • Clearblue




  • Piramal Healthcare




Ovulation Test Industry Developments


June 2021:The distribution of the REVEAL Rapid AST system by particular diagnoses in Europe was announced by bioMérieux, strengthening the market for rapid testing kits in the continent.


April 2021:Through the Real Talk with Conceiving Hood Campaign, actress Jordana Brewster and Clearblue® raised awareness about the challenges of conception and women's fertility.


Ovulation Test Market Segmentation


Ovulation Test Type Outlook




  • Urine-based Tests




  • Saliva-based Tests




  • Other Tests




Ovulation Test Application Outlook




  • Hospital




  • Home Care Settings




  • Clinics




  • Others




Ovulation Test Regional Outlook



  • North America

    • US

    • Canada



  • Europe

    • Germany

    • France

    • UK

    • Italy

    • Spain

    • Rest of Europe



  • Asia-Pacific

    • China

    • Japan

    • India

    • Australia

    • South Korea

    • Australia

    • Rest of Asia-Pacific



  • Rest of the World

    • Middle East

    • Africa

    • Latin America



Report Attribute/Metric Details
Market Size 2022 USD 2.5 Billion
Market Size 2023 USD 2.7 Billion
Market Size 2032 USD 4.3 Billion
Compound Annual Growth Rate (CAGR) 6.30% (2023-2032)
Base Year 2023
Market Forecast Period 2024-2032
Historical Data 2019- 2022
Market Forecast Units Value (USD Billion)
Report Coverage Revenue Forecast, Market Competitive Landscape, Growth Factors, and Trends
Segments Covered Type, Application, and Region
Geographies Covered North America, Europe, Asia Pacific, and the Rest of the World
Countries Covered The U.S., Canada, German, France, U.K, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil
Key Companies Profiled Fairhaven Health LLC, Fertility Focus Limited, NecLife, Swiss Precision Diagnostics GmbH, HiLin Life Products Inc., Geratherm Medical AG, Accuquik, Church & Dwight Co. Inc., Prestige Brands Holdings Inc., Clearblue, and Piramal Healthcare
Key Market Opportunities High adoption of kits for ovulation and pregnancy testing
Key Market Dynamics Rising various types of diseases such as Polycystic Ovary Syndrome (PCOS) and other health issues and increased number of first-time pregnancies and low fertility rates across the globe


Frequently Asked Questions (FAQ) :

The Ovulation Test market size was valued at USD 2.5 Billion in 2022.

The market is projected to grow at a CAGR of 6.30% during the forecast period, 2023-2032.

North America had the largest share in the market

The key players in the market are Fairhaven Health LLC, Fertility Focus Limited, NecLife, Swiss Precision Diagnostics GmbH, HiLin Life Products Inc., Geratherm Medical AG, Accuquik, Church & Dwight Co. Inc., Prestige Brands Holdings Inc., Clearblue, and Piramal Healthcare

The Urine-based Tests Type dominated the market in 2022.

The Home Care Settings Application had the largest share in the market.

Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Kindly complete the form below to receive a free sample of this Report
Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.